Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POWERRANGER: Preoperative Chemotherapy vs Chemoradiation in Esophageal Cancer
NCT01404156Phase 3Completed
- Start
- Sep 2015
- Primary completion
- Aug 2023
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, Paclitaxel Micelles for Injection in esophageal adenocarcinoma (EAC), gastroesophageal junction adenocarcinoma. Started Sep 2015; status: completed.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
esophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01404156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404156.